GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Esgen Acquisition Corp (NAS:ESAC) » Definitions » Change In Payables And Accrued Expense

Esgen Acquisition (Esgen Acquisition) Change In Payables And Accrued Expense : $4.40 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Esgen Acquisition Change In Payables And Accrued Expense?

Esgen Acquisition's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was $0.66 Mil. It means Esgen Acquisition's Accounts Payable & Accrued Expense increased by $0.66 Mil from Jun. 2023 to Sep. 2023 .

Esgen Acquisition's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $1.58 Mil. It means Esgen Acquisition's Accounts Payable & Accrued Expense increased by $1.58 Mil from Dec. 2021 to Dec. 2022 .

Esgen Acquisition Change In Payables And Accrued Expense Historical Data

The historical data trend for Esgen Acquisition's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Esgen Acquisition Change In Payables And Accrued Expense Chart

Esgen Acquisition Annual Data
Trend Dec21 Dec22
Change In Payables And Accrued Expense
- 1.58

Esgen Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.81 1.30 1.63 0.66

Esgen Acquisition Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Esgen Acquisition Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Esgen Acquisition's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Esgen Acquisition (Esgen Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Esgen Acquisition Corp (NAS:ESAC) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
SHAP BYNO TGLO PRSR ENER KNSW XFIN TWOA TCOA PFTA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
5956 Sherry Lane, Suite 1400, Dallas, TX, USA, 75225
Website
Esgen Acquisition Corp is a blank check company.
Executives
Larry L Helm director 1000 LOUISIANA, SUITE 5600, HOUSTON TX 77002
James P. Benson director 5956 SHERRY LANE, SUITE 900, DALLAS TX 75225
Mark M Jacobs director 1111 LOUISIANA STREET, HOUSTON TX 77002
Andrea Bernatova director, officer: CEO and Director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Esgen Llc 10 percent owner 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Nader Daylami officer: Chief Financial Officer 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Michael C Mayon director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Sanjay Bishnoi director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225